Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T79580 | Antitumor agent-115 | Apoptosis | Apoptosis |
Antitumor agent-115 (SS-12)是一种在体外展现出显著抗肿瘤活性的化合物,针对小鼠乳腺癌细胞系4T1的IC50值介于0.34 μM至24.14 μM。该化合物能够阻断4T1细胞周期、降低其线粒体膜电位并诱导凋亡,其对4T1细胞抑制活性的IC50值在8-25 μmol/L之间,适用于乳腺癌研究领域。 | |||
T83078 | Anticancer agent 33 | ||
Anticanceragent 33 (compound 3) 为Squamocin与Bullatacin衍生物,展现出有效的抗癌特性。本化合物对4T1乳腺癌细胞系(包括A549、HeLa、HepG2和MCF-7细胞)的生长抑制作用显著,其IC50范围为1.9-5.4 µM。 | |||
T71293 |
Nifuroxazide-d4
|
||
Nifuroxazide-d4 is intended for use as an internal standard for the quantification of nifuroxazide by GC- or LC-MS. Nifuroxazide is a nitrofuran antibiotic. It is active against strains of the enteropathogenic bacteria C. jejuni, Salmonella, Y. enterocolitica, Shigella, and E. coli. It inhibits quorum sensing and virulence factor production in P. aeruginosa. Nifuroxazide inhibits STAT3 activity in a reporter assay and decreases viability of U266 and INA-6 myeloma cells, which have constitutive S... | |||
T35491 |
3,5-dimethyl PIT-1
|
||
PtdIns-(3,4,5)-P3 (PIP3) serves as an anchor for the binding of signal transduction proteins bearing pleckstrin homology (PH) domains such as phosphatidylinositol 3-kinase (PI3K) or PTEN. Protein binding to PIP3 is important for cytoskeletal rearrangement and membrane trafficking and initiates an intricate signaling cascade that has been implicated in cancer. 3,5-dimethyl PIT-1 is a dimethyl analog of PIT-1, the selective inhibitor of PIP3/Akt PH domain binding, that is designed for more favorab... | |||
T79714 |
HDAC3-IN-2
|
HDAC | Chromatin/Epigenetic; DNA Damage/DNA Repair |
HDAC3-IN-2 (compound 4i) 是一种具有纳摩尔级效力的吡嗪酰肼基HDAC3抑制剂,IC50值为14 nM,针对三阴性乳腺癌细胞表现出高效抑制作用。该化合物在细胞内毒性测定中显示,对4T1细胞株的IC50为0.55 μM,对MDA-MB-231细胞株的IC50为0.74 μM。HDAC3-IN-2通过增加乙酰化水平(如H3K9、H3K27和H4K12),促进细胞凋亡(涉及caspase-3、caspase-7和细胞色素c的水平提升),并抑制细胞增殖相关蛋白(如Bcl-2、CD44、EGFR和Ki-67)的表达,从而在荷瘤小鼠模型中表现出显著的体内抗肿瘤作用。 |